Sarcomeric actin genes, c-cardiac and a-skeletal, are coexpressed in neonatal rodent hearts and are regulated in response to hormonal and hemodynamic stimuli; however, their precise developmental pattern of expression has not been determined, and it is unknown whether they are coexpressed during senescence. We have, therefore, investigated the accumulation of sarcomeric actin transcripts in rat heart during fetal and postnatal development and with senescence by two different techniques: primer extension analysis with an oligonucleotide common to both sarcomeric actins and RNA hybridization with specific cardiac a-actin cRNA probes. We found that at 17-19 days in utero both isogenes are coexpressed and ce-skeletal actin mRNAs represent 28.0+0.8% of the sarcomeric actin mRNA total. Skeletal actin mRNAs increase to 40% of the total 1 week after birth (NS, p=0.15), remain constant for 3 weeks, and decrease to less than 20%o of the total in ventricles and atria of 1-month-old rats. The a-skeletal actin transcripts further decline to less than 5% of the total at 2 months of age and do not reaccumulate in senescent animals. There was no significant diflerence between male and female rat ventricles. By comparison with the known accumulations of aY-and fl-myosin heavy chain mRNAs, our results demonstrate that whatever the developmental stage the kinetics of expression for the sarcomeric myosin and actin multigene families are independent. (Circulation Research 1992;70:999-1005) KEY WORDS * a-skeletal actin * av-cardiac actin * development * aging * rat
In mammals, six different actin isoforms are known to exist, two of which, a-skeletal and a-cardiac, are found only in striated muscles.' Among animal species and muscle types, the quantity of the actin isoforms varies dramatically with development or physiological and pathological conditions.2 These two isoforms are almost identical, differing by only four amino acids over 375 residues.' Two of the four differences are located at the amino terminus, the region of the protein that binds myosins. Because of the close similarity between the sarcomeric actin isoforms and, consequently, the difficulty in measuring the abundance of these proteins in striated muscle, it has proven advantageous to study the relative mRNA accumulations of the actin isoforms. These transcripts are the products of two different genes whose nucleic acid sequences are highly conserved,3,4 excluding their 5' and 3' untranslated regions, which markedly differ5s6 and can be used to unambiguously distinguish between the two mRNA isoforms. A number of studies have taken advantage of these differences to show that the amounts of each isoactin mRNA, like that for the proteins, vary with species, muscle type, and development; however, most studies were conducted with skeletal muscle, and less is known for cardiac muscle.
In humans, both sarcomeric actin mRNAs are coexpressed4'7'8; the a-skeletal actin mRNA isoforms represent a minor part of the sarcomeric actins in fetal hearts that increase after birth and accumulate to higher levels than those for the a-cardiac actin mRNAs in adults. 8 In chick heart, the sarcomeric actin transcripts accumulate in similar proportions as early as 2.5 days in ovo, and in adults, the a-cardiac mRNA isoforms predominate substantially over the skeletal form. 9 In mouse hearts, the two sarcomeric actins are coexpressed in utero (7.5 days postcoitus)10 and the a-skeletal actin declines after birth. To precisely determine the developmental regulation of actin mRNA isoform accumulations, the percentage of a-skeletal to sarcomeric actin mRNAs in rat ventricles and atria was quantitated by primer extension. Figure 1 shows an autoradiogram obtained from total liver, skeletal muscle, and cardiac RNA samples; the FIGURE 1. Primer extension analysis of rat cardiac ventricular RNAs during development and aging. Primer extensions were performed with 10 pg total RNA from rat skeletal muscle (Sk), liver (L), and ventricles at the indicated ages. The molecular weight markers (MW) are indicated in the first column. No signals were generated from liver RNA. In skeletal muscle, only one product, which has a length of 186 nucleotides, was detected. From cardiac RNA, two fragments were generated, one corresponded to a-cardiac actin (a-card, 195 nucleotides) and the other to a-skeletal actin (a-skel, 186 nucleotides).
cardiac RNAs were isolated from ventricles of developing, adult, and aged rats. Only one signal with an apparent length of 186 nucleotides was detected from rat skeletal muscle RNAs. No signals were detected from liver RNAs, indicating the specificity of our assay for sarcomeric actins. With cardiac RNA, two signals were detected, one of which comigrates with that from skeletal muscle and a second one that has an apparent length of 195 nucleotides. These two signals represent a-skeletal and a-cardiac actin mRNAs, respectively. As can be readily distinguished in the figure, the signals for a-skeletal actin relative to a-cardiac actin decrease with age.
Complete analysis of the primer extension assays indicates that the sarcomeric actins are nearly always coexpressed in rat ventricles but that the relative level of expression varies dramatically with age ( Figure 2 ). At 17 and 19 days in utero (-0.5 weeks), a-skeletal actin mRNAs represent 28.1±0.8% of the total, its proportion increases 8 days after birth to 44±7.6% (NS, p=0.15) and remains constant for 3 weeks, decreases by 1 month of age to 15.2+2.9%, and represents in aged rat ventricles only 3.4±3.0% of the total. Thus, in late fetal and neonatal rat ventricles, a-skeletal actins can account for as much as 50% of the total and in senescent rat ventricles almost never more than 5% of the total. This greater than 10-fold decrease with age corresponds well with the decrease of 11-fold reported by Mayer et a16 but more importantly demonstrates that a-skeletal actin transcripts never constitute a majority of the sarcomeric actins in late fetal to adult rat ventricles. To ensure that these results were not skewed by sex-related factors, RNAs were analyzed from male and female rats aged 3-6 weeks ( Figure 3 ). During this time, the rats develop into sexually mature adults. No significant difference in the percentage of a-skeletal to sarcomeric actin mRNA could be demonstrated between the two groups at any of these ages. These data indicate that the accumulation of the a-skeletal actin mRNAs are not linked to the sex of the animal or, more precisely, to potential hormonal changes occurring during this period of development.
To determine whether the downregulation of the a-skeletal actin mRNA is specific to the ventricles or is a common feature of the whole heart, the developmental regulation of the atria (left and right) was also studied, but only from rats between 3 weeks and 24 months of age because of the difficulty in physically isolating this tissue from fetal and neonatal rat hearts. The results are presented in Table I along with the corresponding values obtained from the ventricles. The calculated percentages of the a-actins in the two tissues roughly correspond at all ages studied. It is thus probable that the sarcomeric actins are developmentally regulated in the atria; i.e., a-skeletal actin mRNAs are downregulated with age. However, it is impossible to say from our results if a-skeletal actins represent a significant fraction of the total in fetal and neonatal atria.
Sarcomeric Actin mRNAs Decrease With Development
Although we demonstrated that the a-skeletal actin mRNAs transiently accumulate during early development and subsequently decrease with age, it was important to know whether these changes were due to a reduced accumulation of both sarcomeric ca-actin mRNAs or a relative increase in a-cardiac actin transcripts. For this determination, a labeled cRNA probe specific for a-cardiac actin was prepared from pBSa, and used to determine the amount of a-cardiac actin transcripts in total ventricular RNA samples with development. Typical data from this experiment are shown in Figure 4 . The cardiac cRNA probe strongly hybridized with cardiac RNA, whereas no detectable signals were seen from liver-or skeletal muscle-derived RNAs. The relatively homogeneous intensity of expression for all the neonatal and aged rat heart samples suggested that a-cardiac actin accumulations are unchanged with dea-card poly (A+)
. Figure 5 summarize the developmental changes of expression for both sarcomeric a-actins. Data were calculated from the percentages of a-actins determined by primer extension analyses and from the normalized values obtained from slot blot analysis. As can be seen, both a-skeletal and a-cardiac actin transcripts decreased with postnatal development and senescence relative to neonates at 23 days by 2.0-and 1.4-fold, at 2 months by 12.5-and 1.4-fold, and at 24 months by 8.3-and 1.8-fold, respectively. With time, the accumulations of total sarcomeric actin mRNAs decrease by 1.5- 5 . Graphic representation of the sarcomeric actin mRNA accumulations with development and aging. Data for this graph were obtained from the actual data of Table 2 . The contributions of a-cardiac and a-skeletal actin are represented by the stipled and empty portions of the bars, respectively, and indicate that the total amount of sarcomeric actin decreases by >50% with aging. AU, arbitrary units. 3.4-fold increase in accumulation of the a-cardiac transcripts with heart development. This discrepancy could be partially explained by differences in the techniques used for the analyses. Finally, the slight decrease of total sarcomeric actin transcripts with aging cannot alone account for the -12-fold decrease of a-skeletal actin seen with senescence and demonstrates that the decrease in a-skeletal actin mRNAs results from a downregulation of its expression.
Discussion In this study we have determined the precise time course of expression of the a-cardiac and a-skeletal actin isogenes in the rat heart during ontogeny and aging, and we have shown that a-skeletal actin transcripts do not reaccumulate with aging. We also showed that both these transcripts are present in the atria and ventricles, that their expressions do not appear to be dependent on sex-related factors, and that the accumulations for both sarcomeric actins decrease with aging.
These findings extend our understanding of the developmental and age-related regulations of the actin gene products and suggest important differences in the regulation of the genes coding for the sarcomeric proteins of heart muscle. To emphasize these differences, we have compared the relative percentages of a-skeletal/sarcomeric actin mRNAs with those of ,B-MHC/ a+ 3-MHC mRNAs ( Figure 6 ). It is immediately apparent that the accumulations for these transcripts with ontogeny and senescence are distinct and independent.
For example, just after birth the a-skeletal actin transcripts accumulate to .40% and then slowly decrease to <5% of the total at age 2 months (this study). Meanwhile, the fl-MHC transcripts decrease rapidly from >50% to <2% of the total by age 3-4 weeks13; afterward, they reaccumulate to eventually attain levels of -85% with senescence.14 With cardiac hypertrophy induced by thoracic aortic constriction, these two mRNAs are also known to accumulate in a spatially and temporally distinct manner. 20 In humans, a-skeletal actin transcripts increase after birth, accumulate to levels greater than those for the cardiac actin mRNAs in adults, and remain at these same adult levels even with end-stage heart failure,8 whereas /3-MHC remains preponderant at all stages of development, age, and disease. 21 do not exactly correspond to those of the sarcomeric a-actins. These differences may, therefore, at least partially explain the distinct patterns of expression of these genes during growth and development.
In conclusion, our results provide additional evidence of independent regulations for the sarcomeric a-actins and the a-and 1-MHCs. Measurement of RNA accumulations alone are insufficient for one to determine at what level these multigene families are regulated. Transcriptional events are undoubtedly involved,30 but a number of posttranscriptional and translational controls must also be considered before one will be able to understand the complex regulations necessary for the coordinated expression of the functioning sarcomere.
